Zobrazeno 1 - 10
of 641
pro vyhledávání: '"PSA Failure"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laura Happersett, Neelam Tyagi, Michael J. Zelefsky, Achiraya Teyateeti, Attapol Pinitpatcharalert, Daniel Gorovets, Margaret Hopkins, Sean McBride, Zhigang Zhang, Behfar Ehdaie, Victor E. Reuter, Marisa A. Kollmeier, Debra A. Goldman, Samson W. Fine
Publikováno v:
Radiother Oncol
PURPOSE: To investigate predictors associated with post-treatment biopsy outcomes after stereotactic body radiotherapy (SBRT) for localized prostate cancer. MATERIALS AND METHODS: 257 patients treated with prostate SBRT to dose levels of 32.5 Gy to
68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
Autor:
Ken Le, Celi Varol, Mohamed Khadra, Matthew Winter, Chris Rothe, Bertram Canagasingham, Diep N. Nguyen, Mohan Arianayagam, Raymond Ko, Kieran Beattie, Richard Ferguson, Chuong Bui, Jonathan Kam, Yuigi Yuminaga
Publikováno v:
Asian Journal of Urology, Vol 8, Iss 2, Pp 170-175 (2021)
Asian Journal of Urology
Asian Journal of Urology
Purpose To evaluate the use of Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA PET/CT), compared with conventional CT abdomen/pelvis (CTAP) and whole body single photon emission computed tomog
Autor:
Michael J. Zelefsky, Attapol Pinitpatcharalert, Sean McBride, Laura Happersett, Neelam Tyagi, Marisa A. Kollmeier, Daniel Gorovets, Debra A. Goldman, Melissa Varghese, Margie Hunt, Zhigang Zhang
Publikováno v:
Eur Urol Oncol
BACKGROUND: Studies using stereotactic body radiotherapy (SBRT) dose escalation in in low- and intermediate-risk prostate cancer patients have indicated favorable outcomes. OBJECTIVE: To evaluate tolerance and tumor control outcomes in low- and inter
Publikováno v:
Journal of Endoluminal Endourology. 3:e22-e30
Background and ObjectivesMinimally invasive methods are expected to avoid the risk of overtreatment and overtreatment of radical therapy to manage the increased number of patients with low-volume, low-grade localized prostate cancer. Based on our exp
Publikováno v:
Journal of Endourology. 34:441-449
Purpose: Specimen pathology findings collectively impact the long-term outcomes of robot-assisted laparoscopic prostatectomy. Since seminal vesicle invasion (SVI) is an important independent predic...
Autor:
Jeremy Clark, Bogdan-Alexandru Luca, Dylan R. Edwards, Vincent Moulton, Rosalin Cooper, Colin Cooper, Colin Campbell, Christopher Ellis, Daniel Brewer
Publikováno v:
British Journal of Cancer
Background Unsupervised learning methods, such as Hierarchical Cluster Analysis, are commonly used for the analysis of genomic platform data. Unfortunately, such approaches ignore the well-documented heterogeneous composition of prostate cancer sampl
Autor:
Steven N. Seyedin, Joseph M. Caster, Chad R. Tracy, John M. Watkins, J. Kyle Russo, Zachary Mayo, Anthony N. Snow, Michael Laszewski, John M. Buatti, Mark C. Smith, Sarah L. Mott
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100778-(2021)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose The cohort of patients with locally advanced prostate cancer (PC) and positive surgical margin(s) at radical prostatectomy (RP) who would benefit from salvage or adjuvant treatment is unclear. This study examines the risk of prostate-specific
Autor:
Peter R. Carroll, Scott A. Greenberg, Samuel L. Washington, Hao G. Nguyen, Peter E. Lonergan, Janet E. Cowan
Publikováno v:
The ProstateREFERENCES. 81(13)
Background A detectable prostate-specific antigen (PSA) following radical prostatectomy (RP) is an unfavorable prognostic factor. However, not all men with a detectable PSA experience recurrence. We describe the natural history and outcomes in men wi
Autor:
Gislane Rocha Vasconcelos, Conceição Aparecida Dornelas, Carlos Gustavo Hirth, Maria do Perpétuo Socorro Saldanha da Cunha, Carlos Heli Bezerra Leite
Publikováno v:
Annals of diagnostic pathology. 56
CUL2 plays a crucial role in proteolysis by preserving the balance between normal growth and uncontrolled proliferation. HSPA9 safeguards the integrity of protein interactions and supports cellular homeostasis. In carcinomas, HSPA9 and CUL2 appear to